Hey LARVOL fam! Today, we've managed to grab some precious moments with our very own VP Oncology, Dr. Mark Gramling. We've got science, guitars, and comedy skits on the docket, so let's dive right in!
Dr. Mark Gramling: I’ve been with LARVOL in two separate tentures. For my first, I focused on developing services supporting healthcare and clinical trials. In my second tenure, I’ve focused on building and developing existing and new products in oncology.
Dr. Mark Gramling: I like to describe myself as a “recovering scientist”. For my undergrad, I studied biochemistry and microbiology and figured if I did that I would pursue a PhD in pathology examining disease mechanisms. I found the preclinical models of oncology the most intriguing and chose to continue pursuing that in my postdoctoral studies. After my post-doctoral studies, I saw a job posting for supporting market intelligence reports that was originally part-time for LARVOL - and I guess I’ve never turned back.
Dr. Mark Gramling: There is obviously the remote element - of which LARVOL has been innovative for many years. I love being able to connect to a global team and being part of a company with a team that is always exploring, experimenting, and growing to try new things to support our customers is particularly fulfilling.
Dr. Mark Gramling: Whether a strength or a weakness, I always think about people and my teams first. When you know we’re all dependent upon each other across 10 different time zones to achieve a collective goal, it’s hard not to be motivated by that.
Dr. Mark Gramling: We obviously use both virtual reality but also video conferences, so it wouldn’t surprise my colleagues that I have guitars hanging up all over my house. As much as I try to tell a joke or two in meetings, they might also be surprised how much time I spend delving into the history and the latest in stand up and sketch comedy.
Navigating the busy world of pharmaceutical conferences can be a daunting task, filled with endless sessions, abstracts, and updates to keep track of. This is where LARVOL CONF comes into play – offering a simple, yet powerful way to organize and manage conference information effectively.
The global pandemic caused by COVID-19 has cast a profound impact on nearly every aspect of our lives. Its effects on health, economics, education, and social structures are apparent, but there are less visible but equally significant impacts too.
Key Opinion Leaders (KOLs) play a crucial role in shaping the success of a drug in the pharmaceutical industry.They are influential figures with expertise, credibility, and a wide network within their respective therapeutic areas. Finding the right KOLs for your drug can significantly impact its development, marketing, and adoption.